Dr. Friedemann (born 1985 in Gotha) studied biology and biophysics at the Johan Wolfgang
Goethe-University Frankfurt am Main, the Fudan University in Shanghai and at the Shanghai Research Center of Acupuncture and Meridian. He worked intensively during his
degree on the dynamics of mitochondrial membrane potential and mass during the cell cycle as well as on the regulation of the cardiovascular system through Traditional Chinese Medicine. His first
publications on the topic appeared during a two-year research period at the Shanghai Research Center of TCM. On completion of his degree he joined the HanseMerkur TCM Center at the UKE,
where he focoused his research on neuroprotective and neuroregenerative effects of Chinese medicinal herbs for his PhD. Out of this research several publication emerged in international journals.
In 2015 he received his doctorate at the Hamburg University and became laboratory head at the HanseMerkur TCM Center at the UKE. In 2016 his
research work was Honoured with the Sebastian-Kneipp Award.
In 2017, Dr. Friedemann was elected as a German delegate of the DIN commission ISO-TC-249.
Since 2017 he is Executive Council Member of the 1st Board of Specialty Committee of Evaluation and Promotion of Chinese Medicine Appropriate Technology of the World Federation of Chinese Medicine Societies (WFCMS).
As CEO of ConPhyMed, he is responsible for Scientific and Regulatory Affairs.